JP2023548083A5 - - Google Patents
Info
- Publication number
- JP2023548083A5 JP2023548083A5 JP2023525049A JP2023525049A JP2023548083A5 JP 2023548083 A5 JP2023548083 A5 JP 2023548083A5 JP 2023525049 A JP2023525049 A JP 2023525049A JP 2023525049 A JP2023525049 A JP 2023525049A JP 2023548083 A5 JP2023548083 A5 JP 2023548083A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- polypeptide
- acid sequence
- sequence
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063108163P | 2020-10-30 | 2020-10-30 | |
| US63/108,163 | 2020-10-30 | ||
| PCT/US2021/057197 WO2022094177A1 (en) | 2020-10-30 | 2021-10-29 | Compositions and methods for treating celiac sprue disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023548083A JP2023548083A (ja) | 2023-11-15 |
| JP2023548083A5 true JP2023548083A5 (https=) | 2024-11-06 |
Family
ID=78819631
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023525049A Pending JP2023548083A (ja) | 2020-10-30 | 2021-10-29 | セリアックスプルー病を治療するための組成物及び方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20250064903A1 (https=) |
| EP (1) | EP4237554A1 (https=) |
| JP (1) | JP2023548083A (https=) |
| KR (1) | KR20230093323A (https=) |
| CN (1) | CN116829166A (https=) |
| AR (1) | AR123961A1 (https=) |
| AU (1) | AU2021368118A1 (https=) |
| CA (1) | CA3195929A1 (https=) |
| CO (1) | CO2023006731A2 (https=) |
| MX (1) | MX2023004807A (https=) |
| TW (1) | TW202233834A (https=) |
| WO (1) | WO2022094177A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025068987A1 (en) | 2023-09-28 | 2025-04-03 | Takeda Pharmaceutical Company Limited | A method of producing a kumamolisin-as polypeptide |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4475707B2 (ja) * | 1998-10-05 | 2010-06-09 | 武田薬品工業株式会社 | Ｎ末端メチオニンの除去方法 |
| CA2882502A1 (en) | 2011-08-10 | 2013-02-14 | University Of Washington Through Its Center For Commercialization | Compositions and methods for treating celiac sprue disease |
| US10266815B2 (en) * | 2013-08-14 | 2019-04-23 | University Of Washington Through Its Center For Commercialization | Compositions and methods for treating celiac sprue disease |
| NZ737500A (en) * | 2015-06-08 | 2025-02-28 | Univ Washington | Compositions and methods for treating celiac sprue disease |
| AU2017380106B2 (en) * | 2016-12-22 | 2024-05-09 | Ew Nutrition Gmbh | Stable protease variants |
-
2021
- 2021-10-29 MX MX2023004807A patent/MX2023004807A/es unknown
- 2021-10-29 AU AU2021368118A patent/AU2021368118A1/en active Pending
- 2021-10-29 CN CN202180068658.4A patent/CN116829166A/zh active Pending
- 2021-10-29 AR ARP210103015A patent/AR123961A1/es not_active Application Discontinuation
- 2021-10-29 EP EP21816227.9A patent/EP4237554A1/en not_active Withdrawn
- 2021-10-29 US US18/034,622 patent/US20250064903A1/en active Pending
- 2021-10-29 WO PCT/US2021/057197 patent/WO2022094177A1/en not_active Ceased
- 2021-10-29 KR KR1020237017895A patent/KR20230093323A/ko not_active Withdrawn
- 2021-10-29 JP JP2023525049A patent/JP2023548083A/ja active Pending
- 2021-10-29 TW TW110140404A patent/TW202233834A/zh unknown
- 2021-10-29 CA CA3195929A patent/CA3195929A1/en active Pending
-
2023
- 2023-05-24 CO CONC2023/0006731A patent/CO2023006731A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025028857A5 (https=) | ||
| Quax‐Jeuken et al. | beta s‐Crystallin: structure and evolution of a distinct member of the beta gamma‐superfamily. | |
| CN104507489B (zh) | 用于预防和治疗类风湿性关节炎的组合物 | |
| JP2643968B2 (ja) | Ｋｅｘ２エンドプロテアーゼ及びその製造方法 | |
| JP2023181445A5 (https=) | ||
| IL273439B1 (en) | Fusion proteins comprising enzyme replacement therapy enzymes | |
| Nagasawa et al. | Determination of the cleavage site involved in C-terminal processing of penicillin-binding protein 3 of Escherichia coli | |
| HUT73394A (en) | Process for production of protein | |
| JP2015504052A5 (https=) | ||
| JP2020517260A5 (https=) | ||
| FI4034555T3 (fi) | Dap10/dap12-fuusiopolypeptidit | |
| JP2023548083A5 (https=) | ||
| CN105829350A (zh) | 肠激酶可切割的多肽 | |
| WO2022241831A1 (zh) | 多肽的制备方法 | |
| Boraston et al. | Glycosylation by Pichia pastoris decreases the affinity of a family 2a carbohydrate-binding module from Cellulomonas fimi: a functional and mutational analysis | |
| WO2023143563A1 (zh) | IgA蛋白酶截短体、包含IgA蛋白酶截短体的融合蛋白及其用途 | |
| CN106146668A (zh) | 长效白细胞介素22的制备方法及其用途 | |
| CA2076320A1 (en) | Process for producing peptide | |
| JP2024526356A5 (https=) | ||
| CA2450548A1 (en) | Method for the recombinant production of peptidic antiviral fusion inhibitors, and acetylation of gb41 fragments | |
| CN107011430A (zh) | 一种具有生物学活性的截短的生长分化因子11及其制备方法 | |
| JP2015510770A5 (https=) | ||
| JP2021511785A (ja) | 組換えポリペプチド生産用ｎ末端融合パートナーおよびこれを用いた組換えポリペプチドの生産方法 | |
| Ishizaki et al. | Production of recombinant human glucagon in the form of a fusion protein in Escherichia coli; recovery of glucagon by sequence-specific digestion | |
| JP2021514194A (ja) | ブタトリプシンの変異体 |